β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance

β-adrenergic signaling is known to be involved in cancer progression; in particular, beta3-adrenoreceptor (β3-AR) is associated with different tumor conditions. Currently, there are few data concerning β3-AR in myeloid malignancies. Here, we evaluated β3-AR in myeloid leukemia cell lines and the eff...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Calvani, Maura, Dabraio, Annalisa, Bruno, Gennaro, De Gregorio, Veronica, Coronnello, Marcella, Bogani, Costanza, Ciullini, Sara, la Marca, Giancarlo, Vignoli, Marina, Chiarugi, Paola, Nardi, Margherita, Vannucchi, Alessandro Maria, Filippi, Luca, Favre, Claudio
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352890/
https://ncbi.nlm.nih.gov/pubmed/32545695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21124210
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares